These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The biology of Mur ligases as an antibacterial target. Kouidmi I; Levesque RC; Paradis-Bleau C Mol Microbiol; 2014 Oct; 94(2):242-53. PubMed ID: 25130693 [TBL] [Abstract][Full Text] [Related]
4. Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF): experimental and computational characterization. Perdih A; Hrast M; Pureber K; Barreteau H; Grdadolnik SG; Kocjan D; Gobec S; Solmajer T; Wolber G J Comput Aided Mol Des; 2015 Jun; 29(6):541-60. PubMed ID: 25851408 [TBL] [Abstract][Full Text] [Related]
5. Homology modeling and docking analyses of M. leprae Mur ligases reveals the common binding residues for structure based drug designing to eradicate leprosy. Shanmugam A; Natarajan J J Mol Model; 2012 Jun; 18(6):2659-72. PubMed ID: 22102165 [TBL] [Abstract][Full Text] [Related]
6. The Potential of Mur Enzymes as Targets for Antimicrobial Drug Discovery. Kumar D; Sarkar N; Roy KK; Bisht D; Kumar D; Mandal B; Rajagopal M; Dey YN Curr Drug Targets; 2023; 24(8):627-647. PubMed ID: 37291783 [TBL] [Abstract][Full Text] [Related]
7. Identification of Ideal Multi-targeting Bioactive Compounds Against Mur Ligases of Enterobacter aerogenes and Its Binding Mechanism in Comparison with Chemical Inhibitors. Chakkyarath V; Natarajan J Interdiscip Sci; 2019 Mar; 11(1):135-144. PubMed ID: 29086207 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the published kinase inhibitor set to identify multiple inhibitors of bacterial ATP-dependent mur ligases. Hrast M; Rožman K; Ogris I; Škedelj V; Patin D; Sova M; Barreteau H; Gobec S; Grdadolnik SG; Zega A J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1010-1017. PubMed ID: 31072165 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases. Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694 [TBL] [Abstract][Full Text] [Related]
10. Pyrazolopyrimidines establish MurC as a vulnerable target in Pseudomonas aeruginosa and Escherichia coli. Hameed P S; Manjrekar P; Chinnapattu M; Humnabadkar V; Shanbhag G; Kedari C; Mudugal NV; Ambady A; de Jonge BL; Sadler C; Paul B; Sriram S; Kaur P; Guptha S; Raichurkar A; Fleming P; Eyermann CJ; McKinney DC; Sambandamurthy VK; Panda M; Ravishankar S ACS Chem Biol; 2014 Oct; 9(10):2274-82. PubMed ID: 25035921 [TBL] [Abstract][Full Text] [Related]
12. The MurG glycosyltransferase provides an oligomeric scaffold for the cytoplasmic steps of peptidoglycan biosynthesis in the human pathogen Bordetella pertussis. Laddomada F; Miyachiro MM; Jessop M; Patin D; Job V; Mengin-Lecreulx D; Le Roy A; Ebel C; Breyton C; Gutsche I; Dessen A Sci Rep; 2019 Mar; 9(1):4656. PubMed ID: 30874582 [TBL] [Abstract][Full Text] [Related]
13. Mur ligases inhibitors with azastilbene scaffold: Expanding the structure-activity relationship. Hrast M; Frlan R; Knez D; Zdovc I; Barreteau H; Gobec S Bioorg Med Chem Lett; 2021 May; 40():127966. PubMed ID: 33744441 [TBL] [Abstract][Full Text] [Related]
14. Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis. Kotnik M; Anderluh PS; Prezelj A Curr Pharm Des; 2007; 13(22):2283-309. PubMed ID: 17692001 [TBL] [Abstract][Full Text] [Related]
15. [Advances in the research of inhibitors of enzymes of bacterial peptidoglycan biosynthesis]. Liu F; Meng HY; Sun ZY; Li DY; Jin YY; Yang ZY; Wu SJ; Chen J Yao Xue Xue Bao; 2017 Mar; 52(3):362-70. PubMed ID: 29979555 [TBL] [Abstract][Full Text] [Related]
16. 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases. Tomasić T; Zidar N; Kovac A; Turk S; Simcic M; Blanot D; Müller-Premru M; Filipic M; Grdadolnik SG; Zega A; Anderluh M; Gobec S; Kikelj D; Peterlin Masic L ChemMedChem; 2010 Feb; 5(2):286-95. PubMed ID: 20024979 [TBL] [Abstract][Full Text] [Related]
17. Unconventional Antibacterials and Adjuvants. Chang M; Mahasenan KV; Hermoso JA; Mobashery S Acc Chem Res; 2021 Feb; 54(4):917-929. PubMed ID: 33512995 [TBL] [Abstract][Full Text] [Related]
18. The early stage peptidoglycan biosynthesis Mur enzymes are antibacterial and antisporulation drug targets for recurrent Clostridioides difficile infection. Sapkota M; Marreddy RKR; Wu X; Kumar M; Hurdle JG Anaerobe; 2020 Feb; 61():102129. PubMed ID: 31760080 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF. Sova M; Kovac A; Turk S; Hrast M; Blanot D; Gobec S Bioorg Chem; 2009 Dec; 37(6):217-22. PubMed ID: 19804894 [TBL] [Abstract][Full Text] [Related]
20. The MurC ligase essential for peptidoglycan biosynthesis is regulated by the serine/threonine protein kinase PknA in Corynebacterium glutamicum. Fiuza M; Canova MJ; Patin D; Letek M; Zanella-Cléon I; Becchi M; Mateos LM; Mengin-Lecreulx D; Molle V; Gil JA J Biol Chem; 2008 Dec; 283(52):36553-63. PubMed ID: 18974047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]